Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings-Reference-Cited by-同舟云学术

Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings

Published:2003-03 Issue:1-2 Volume:329 Page:39-51
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Bertinchant J.P,Polge A,Juan J.M,Oliva-Lauraire M.C,Giuliani I,Marty-Double C,Burdy J.Y,Fabbro-Peray P,Laprade M,Bali J.P,Granier C,de la Coussaye J.E,Dauzat M

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Biochemistry,General Medicine

Reference45 articles.

1. Doxorubicin-induced cardiomyopathy;Singal;N. Engl. J. Med.,1998

2. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses;Olsen;FASEB J.,1990

3. Assessing anthracycline cardiotoxicity in the 1990s;Carrio;Eur. J. Nucl. Med.,1996

4. Review of tests for monitoring doxorubicin-induced cardiomyopathy;Ganz;Oncology (Basel),1996

5. Cardiac troponin I. A marker with high specificity for cardiac injury;Adams;Circulation,1993

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats;Hypertension Research;2024-09-09

2. A REVIEW ON THE CHEMICAL-INDUCED EXPERIMENTAL MODEL OF CARDIOTOXICITY;International Journal of Pharmacy and Pharmaceutical Sciences;2024-07-01

3. Inflammatory Reprogramming Mediates Changes in Three-Dimensional Strain Capacity and Cardiac Function in Beagle Dogs with Doxorubicin-Related Cardiomyopathy;Reviews in Cardiovascular Medicine;2024-02-18

4. Screening of Myocardial Cardiotoxicity Induced by Anticancer Chemotherapy and the Importance of Global Longitudinal Strain;World Journal of Cardiovascular Diseases;2024

5. Biomarkers in Nonclinical Drug Development;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024